title: Amiodarone induced thyrotoxicosis: diagnostic and therapeutic strategies.
abstract: Amiodarone causes thyrotoxicosis in 3% of US patients who use it. Two types of amiodarone-induced thyrotoxicosis are recognized, designated type 1 and type 2, based on whether or not the patient had a preexisting thyroid disorder. Distinguishing between the two can be difficult, but it is important for providing appropriate therapy promptly.
authors.affiliation: Section of Preventive Cardiology, Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, OH 44195, USA.
authors.forename: Gustavo A
authors.initials: GA
authors.lastname: Cardenas
authors.forename: José M
authors.initials: JM
authors.lastname: Cabral
authors.forename: Camilo A
authors.initials: CA
authors.lastname: Leslie
mesh_terms: D000638:Amiodarone / Q000009:adverse effects* / Q000737:chemistry; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects*; D013956:Antithyroid Agents / Q000627:therapeutic use; D006801:Humans; D007455:Iodine / Q000009:adverse effects; D017410:Practice Guidelines as Topic; D013965:Thyroidectomy; D013971:Thyrotoxicosis / Q000139:chemically induced* / Q000175:diagnosis / Q000628:therapy
chemical_list: D000889:Anti-Arrhythmia Agents; D013956:Antithyroid Agents; D007455:Iodine; D000638:Amiodarone